Division of the Budget
Landon State Office Building Phone: (785) 296-2436
900 SW Jackson Street, Room 504 adam.c.proffitt@ks.gov
Topeka, KS 66612 Division of the Budget http://budget.kansas.gov
Adam C. Proffitt, Director Laura Kelly, Governor


February 14, 2024


The Honorable Brenda Landwehr, Chairperson
House Committee on Health and Human Services
300 SW 10th Avenue, Room 112-N
Topeka, Kansas 66612
Dear Representative Landwehr:
SUBJECT: Fiscal Note for HB 2747 by House Committee on Health and Human
Services
In accordance with KSA 75-3715a, the following fiscal note concerning HB 2747 is
respectfully submitted to your committee.
HB 2747 would permit a pharmacist to screen and initiate prophylactic therapy for a patient
for post-exposure to the human immunodeficiency virus within the statewide protocol adopted by
the Collaborative Drug Therapy Management Committee. Currently, the committee is composed
of three physicians appointed by the Board of Healing Arts and three pharmacists appointed by
the Board of Pharmacy, plus a non-voting Chair from the Board of Pharmacy. This would be a
change from current law which allows the Committee to adopt statewide protocols for a pharmacist
to test the patient and, as appropriate, prescribe and dispense treatment for influenza, strep, and
urinary tract infections. The Committee adopted statewide protocols for these conditions in 2023.
According to the Kansas Board of Pharmacy, enactment of HB 2747 would increase costs
to the Board in the form of staff time and resources necessary to carry out such duties. The Board
estimates that it would possibly increase costs for temporary staff and meetings by $4,320 from
the Board of Pharmacy Fee Fund for FY 2025. Any fiscal effect associated with HB 2747 is not
reflected in The FY 2025 Governor’s Budget Report.


Sincerely,

Adam C. Proffitt
Director of the Budget
cc: Alexandra Blasi, Board of Pharmacy


Statutes affected:
As introduced: 65-16